Table 2.

The blood lipids levels after drugs administration for six weeks (n = 10)

Variables	Control	Model	CMC-Na	Statin	AEE Low	AEE Mid	AEE High
TG (mmol/L)	0.53 ± 0.12**	0.89 ± 0.07	0.79 ± 0.19	0.83 ± 0.05	0.79 ± 0.23	0.77 ± 0.10	0.71 ± 0.07**
HDL (mmol/L)	0.72 ± 0.04	0.74 ± 0.08	0.69 ± 0.09	0.66 ± 0.13	0.73 ± 0.09	0.79 ± 0.10	0.65 ± 0.15
LDL (mmol/L)	0.25 ± 0.02**	0.50 ± 0.09	0.46 ± 0.06	0.39 ± 0.13**	0.45 ± 0.05	0.46 ± 0.10	0.36 ± 0.08**
TCH (mmol/L)	1.4 ± 0.10**	2.29 ± 0.26	2.13 ± 0.22	1.80 ± 0.16**	2.10 ± 0.22*	2.15 ± 0.15	1.66 ± 0.15**

^* P < 0.05, ^** P < 0.01 significant difference compared to model group. TG triglyceride, HDL high density lipoprotein, LDL low density lipoprotein, TCH total cholesterol. Blood lipids indices were increased in model group. The blood lipid levels were reduced in simvastatin and high dose AEE groups in varying degrees